TGA
MRK icon

Trilogy Global Advisors’s Merck MRK Stock Holding History

Trilogy Global Advisors’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-271,267
Closed -$16.6M – 53
2017
Q2 		$16.6M Sell
271,267
-19,415
-7% -$1.18M 0.56% 56
2017
Q1 		$17.6M Sell
290,682
-19,688
-6% -$1.19M 0.59% 60
2016
Q4 		$17.4M Buy
+310,370
New +$18.2M 0.59% 54

Other funds holding MRK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Trilogy Global Advisors's MRK Position: Q3 2017 in Review

Trilogy Global Advisors sold out of Merck (MRK) in Q3 2017, closing a stake of 271,267 shares — an estimated $16.6M sold.

Trilogy Global Advisors first reported a position in MRK in Q4 2016 and held it in 3 quarters. The position peaked at $17.6M in Q1 2017. 1,923 funds tracked by Wall St. Rank hold MRK as of Q3 2017.

  • Trilogy Global Advisors reported no remaining Merck position as of Q3 2017 after selling out during the quarter.
  • Trilogy Global Advisors sold 271,267 Merck shares in Q3 2017, an estimated $16.6M.
  • Trilogy Global Advisors first reported a position in Merck in Q4 2016 and held it in 3 quarters.
  • Trilogy Global Advisors's Merck position peaked at $17.6M in Q1 2017.
  • 1,923 funds tracked by Wall St. Rank held Merck as of Q3 2017.

Based on Trilogy Global Advisors's 13F filing for Q3 2017, filed 13 Nov 2017.